Decline depth
-38.8%
From rolling 252-day high of $27.41, 149d ago.
Past the 30% Amber threshold.
-38.8%
from rolling 252-day high of $27.41 set 2026-04-22 · 149d ago
Current
$16.89
Decline depth
-38.8%
Decline σ
5.9σ
TFC
0/5 bearish
Where it stands
On the Amber List.
Down 38.8% from its rolling 252-day high, 149 days after the high.
Snapshot . Price structure, not a judgment about the business.
What changed
Since the previous observation.
Tier and recovery signal are unchanged between these two observations.
Comparing with . This compares classification, not price returns.
See the recorded timeline →Why it is flagged
CBIO qualifies for the Amber List on decline depth.
Down 38.8% from its rolling 252-day high, 149 days after the high. The most severe triggered rule determines the tier.
Inspect the three classification measures
Time-frame continuity
0/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
5.9σ
Drop over the last 20 bars in units of daily volatility (4.66%/day).
Past the ≥4σ Watch threshold.
Price history
The price path behind the snapshot.
Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.
Rolling 252-day high
Gold dots: recorded classification events (see timeline)
Up day
Down day
90 daily bars from Alpaca · through
The recorded history
A timeline of observations.
First observed 2026-09-09. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.
- Unmatched; coverage or recovery unconfirmed → Amber List
- Watch → Unmatched; coverage or recovery unconfirmed
- First observed: Watch
Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.
Technical interpretation and signal details
The structural read
What price action says about CBIO.
CBIO qualifies for the Amber List on decline depth — down -38.8% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 5.9σ over 20 bars.
Questions about CBIO
What people ask.
Why is CBIO on Broken Stocks?
CBIO qualifies for the Amber List on decline depth. It is down -38.8% from its rolling 252-day high of $27.41, set on 2026-04-22 — 149d ago.
Is CBIO a falling knife?
Not by the strict technical definition. CBIO is down -38.8% from its 52-week high, but that high was set 149d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. CBIO is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is CBIO a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is CBIO trading inside its 52-week range?
At $16.89, CBIO sits 43.7% of the way from its 52-week low ($8.72) to its 52-week high ($27.41). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has CBIO been declining?
The current 38.8% decline accrued over 149d, which annualizes to roughly -95.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does CBIO compare to its sector?
There are 344 other Healthcare tickers on Broken Stocks: 199 Red, 86 Amber, 59 Watch, with 168 showing recovering structural signals. Median sector decline is -36.5% — CBIO's decline is deeper than the sector median.